BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1769286)

  • 1. Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine-needle aspirates.
    Masood S; Frykberg ER; McLellan GL; Dee S; Bullard JB
    Diagn Cytopathol; 1991; 7(6):581-90. PubMed ID: 1769286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine needle aspiration biopsy of proliferative breast disease.
    Thomas PA; Cangiarella J; Raab SS; Waisman J
    Mod Pathol; 1995 Feb; 8(2):130-6. PubMed ID: 7777472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclassification of benign breast disease by fine needle aspiration cytology. Comparison of cytologic and histologic findings in 265 palpable breast masses.
    Maygarden SJ; Novotny DB; Johnson DE; Frable WJ
    Acta Cytol; 1994; 38(2):115-29. PubMed ID: 8147200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gray zone in breast fine needle aspiration cytology. How to report on it?
    Ozkara SK; Ustün MO; Paksoy N
    Acta Cytol; 2002; 46(3):513-8. PubMed ID: 12040646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographically detected breast lesions: clinical importance of cytologic atypia in stereotaxic fine-needle aspiration biopsy samples.
    Mitnick JS; Vazquez MF; Feiner HD; Pressman P; Roses DF
    Radiology; 1996 Feb; 198(2):319-22. PubMed ID: 8596824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities.
    Sneige N; Tulbah A
    Diagn Cytopathol; 2000 Jul; 23(1):29-34. PubMed ID: 10907929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can nonproliferative breast disease and proliferative breast disease without atypia be distinguished by fine-needle aspiration cytology?
    Frost AR; Aksu A; Kurstin R; Sidawy MK
    Cancer; 1997 Feb; 81(1):22-8. PubMed ID: 9100537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.
    Mridha AR; Iyer VK; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):334-40. PubMed ID: 17001879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographically guided fine-needle aspiration of nonpalpable breast lesions.
    Helvie MA; Baker DE; Adler DD; Andersson I; Naylor B; Buckwalter KA
    Radiology; 1990 Mar; 174(3 Pt 1):657-61. PubMed ID: 2305045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions.
    Burns RP; Brown JP; Roe SM; Sprouse LR; Yancey AE; Witherspoon LE
    Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
    Simsir A; Waisman J; Thorner K; Cangiarella J
    Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic fine-needle aspiration for cytologic diagnosis of nonpalpable breast lesions.
    Löfgren M; Andersson I; Lindholm K
    AJR Am J Roentgenol; 1990 Jun; 154(6):1191-5. PubMed ID: 2110726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of calponin and smooth muscle myosin heavy chain in fine-needle aspiration biopsies of the breast.
    Dabbs DJ; Gown AM
    Diagn Cytopathol; 1999 Apr; 20(4):203-7. PubMed ID: 10204102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of estrogen receptor immunocytochemical assay to aspirates from mammographically guided fine needle biopsy of nonpalpable breast lesions.
    Masood S; Frykberg ER; McLellan GL; Bullard JB
    South Med J; 1991 Jul; 84(7):857-61. PubMed ID: 1712514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions.
    Garg S; Mohan H; Bal A; Attri AK; Kochhar S
    Diagn Cytopathol; 2007 Nov; 35(11):681-9. PubMed ID: 17924407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine needle aspiration of breast lesions in women aged 30 and under.
    Maygarden SJ; McCall JB; Frable WJ
    Acta Cytol; 1991; 35(6):687-94. PubMed ID: 1950316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.